Rockwell Medical, Inc.
RMTI
$0.80
-$0.04-4.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.35M | 15.93M | 16.07M | 18.91M | 24.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.35M | 15.93M | 16.07M | 18.91M | 24.67M |
| Cost of Revenue | 14.47M | 13.66M | 13.57M | 15.87M | 21.03M |
| Gross Profit | 3.88M | 2.27M | 2.50M | 3.04M | 3.63M |
| SG&A Expenses | 4.28M | 3.86M | 3.85M | 4.40M | 4.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.74M | 17.51M | 17.42M | 20.27M | 25.18M |
| Operating Income | -398.00K | -1.58M | -1.35M | -1.36M | -519.00K |
| Income Before Tax | -554.00K | -1.75M | -1.49M | -1.52M | -756.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -554.00K | -1.75M | -1.49M | -1.52M | -756.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -554.00K | -1.75M | -1.49M | -1.52M | -756.00K |
| EBIT | -398.00K | -1.58M | -1.35M | -1.36M | -519.00K |
| EBITDA | 148.00K | -1.04M | -786.00K | -821.00K | 24.00K |
| EPS Basic | -0.01 | -0.05 | -0.05 | -0.04 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.03 | -0.03 | -0.03 | -0.01 |
| EPS Diluted | -0.02 | -0.05 | -0.05 | -0.04 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.03 | -0.03 | -0.03 | -0.01 |
| Average Basic Shares Outstanding | 39.41M | 36.02M | 34.31M | 34.11M | 32.88M |
| Average Diluted Shares Outstanding | 39.41M | 36.02M | 34.31M | 34.11M | 32.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |